Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma
Clinical trial NCT00782756 · COMPLETED
Trial details
- NCT number
- NCT00782756
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-28
- Primary completion
- 2017-03-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.